Medicare Advantage Insurers Made Nearly 50 million Prior Authorization Determinations in 2023 

In 2023, Medicare Advantage insurers made nearly 50 million prior authorization determinations, reflecting a steady increase in the volume of these requests over the past few years. This trend underscores the growing reliance on prior authorization as a tool for managing healthcare services and costs in the Medicare Advantage program. In this article, we will explore the implications of this data for healthcare providers and patients, including the challenges posed by prior authorization requirements, the variations in practices among insurers, and the potential for future regulatory changes. 

Understanding Prior Authorization in Medicare Advantage 

Prior authorization is a process whereby Medicare Advantage insurers require healthcare providers to obtain approval before delivering certain services or treatments. This mechanism is designed to ensure that services are medically necessary and to control costs. Nearly 99% of Medicare Advantage enrollees are subject to prior authorization requirements, particularly for higher-cost services such as inpatient hospital stays, skilled nursing facility stays, and chemotherapy. In contrast, traditional Medicare has a more limited scope of services that require prior authorization, including certain outpatient hospital services and durable medical equipment. 

The use of prior authorization is a contentious issue within the healthcare system. While it can help to contain costs and improve patient safety by ensuring that services are appropriate, it also introduces administrative burdens for providers and can delay access to necessary care for patients. As the number of prior authorization determinations increases, it raises concerns about the efficiency of care delivery and the impact on patient outcomes. 

Trends in Prior Authorization Requests 

The data from the Centers for Medicare & Medicaid Services (CMS) indicates that the number of prior authorization determinations has risen consistently since 2021. In 2023, the total reached nearly 50 million, compared to 37 million in 2021 and 42 million in 2022. This increase corresponds with a growth in the number of Medicare Advantage enrollees, which rose from 22 million in 2019 to 31 million in 2023. 

On average, there were about two prior authorization determinations per Medicare Advantage enrollee in 2023, consistent with pre-pandemic levels. In comparison, traditional Medicare saw significantly fewer prior authorization reviews, with just under 400,000 requests submitted in fiscal year 2023, highlighting the stark differences in authorization practices between the two programs. 

Denial Rates and Appeals 

In 2023, insurers fully or partially denied approximately 3.2 million prior authorization requests, representing 6.4% of all determinations. This denial rate is slightly lower than the 7.4% observed in 2022. However, the denial rates for traditional Medicare were considerably higher, with 28.8% of requests denied in 2023. These figures underscore the variability in authorization practices and outcomes based on the type of Medicare coverage. 

Despite the number of denials, only a small percentage of these requests were appealed. In Medicare Advantage, 11.7% of denied requests were appealed in 2023, a notable increase from 7.5% in 2019. However, the low appeal rates raise questions about patient awareness and the willingness of providers to challenge decisions. In contrast, most appeals in Medicare Advantage were successful, with 81.7% being partially or fully overturned. This discrepancy indicates potential issues with initial approval processes and highlights the need for better communication and transparency between insurers and providers. 

The Administrative Burden on Providers 

The rise in prior authorization requests has significant implications for healthcare providers. The administrative burden associated with submitting requests, tracking approvals, and managing denials can strain resources, particularly for smaller practices. The requirement for prior authorization can lead to delays in patient care, as providers must wait for approval before delivering necessary services. 

These delays can have serious consequences for patients, especially those requiring timely interventions. For instance, patients with acute conditions or those needing ongoing treatments may experience negative health outcomes if their care is postponed due to prior authorization hurdles. Moreover, the complexity of the process can create frustration for both providers and patients, potentially damaging the patient-provider relationship. 

Variations Among Insurers 

The use of prior authorization is not uniform across Medicare Advantage insurers. In 2023, the volume of determinations and denial rates varied significantly among different insurers. For instance, Humana and Anthem had the highest number of prior authorization determinations per enrollee, while UnitedHealthcare had a lower rate but a higher denial rate. This variation can impact patient experiences and outcomes, as enrollees may face different hurdles depending on their chosen insurer. 

Additionally, some insurers have implemented programs to streamline the prior authorization process, such as “gold carding,” which exempts certain providers from the requirement based on their history of compliance. These initiatives can alleviate some administrative burdens but may not be available to all providers or enrollees. 

Future Directions and Regulatory Changes 

The Biden Administration has taken steps to address concerns surrounding prior authorization in Medicare Advantage. CMS has finalized rules aimed at clarifying criteria for prior authorization policies, streamlining the approval process, and evaluating the impact of these policies on patients with social risk factors. However, ongoing legislative efforts to reform prior authorization practices have faced challenges, with bipartisan support not translating into enacted legislation. 

Looking ahead, the incoming administration may have the opportunity to modify or finalize proposed changes to prior authorization requirements. As lawmakers continue to scrutinize these practices, it is crucial for stakeholders—including providers, insurers, and patient advocacy groups—to engage in discussions about the future of prior authorization in Medicare Advantage. 

The nearly 50 million prior authorization determinations made by Medicare Advantage insurers in 2023 highlight the growing significance of this process in managing healthcare services. While prior authorization can serve important functions in ensuring medically necessary care, it also poses challenges for providers and patients alike. As the landscape continues to evolve, it will be essential for stakeholders to work collaboratively to improve the process, enhance transparency, and ensure that patients receive timely and appropriate care.